Joanna Smith - June 3, 2025 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Rebecca Tollervey - March 11, 2025 Innovations in antibody-drug conjugates and bispecific antibodies – what you need to know - a new special report We are delighted to release our latest report Innovations in antibody-drug conjugates and ...
Joanna Smith - June 10, 2024 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Jacqueline Murphy - November 8, 2023 Validating European patents outside Europe - the Validation State system We are pleased to launch our latest report Validating European patents outside Europe - the ...
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Robert Watson - March 31, 2023 UK accession to the CPTPP - grace period exemption big boost for IP The UK government announced 5 years ago its intention to join the CPTPP (Comprehensive and ...
Jacqueline Murphy - March 7, 2023 Come and join us for a ‘Celebration of all things Singapore’ We are excited to be in Singapore for INTA 2023 and very much hope that you can join us at our ...
Robert Watson - March 2, 2023 Julie Carlisle and Robert Watson in PharmaTimes — everything I own? Featured in PharmaTimes, Julie Carlisle and Robert Watson dig deep into the maelstrom of ...
Maria Hall - October 14, 2022 Robert Watson elected President of FICPI’s Study and Work Committee Partner Robert Watson was elected President of FICPI’s Study and Work Committee (Commission d'Etude ...
Jacqueline Murphy - July 4, 2022 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - June 23, 2022 Mewburn Ellis win MIP UK Patent Prosecution Firm of the Year! We are delighted to have been named UK Firm of the Year for Patent Prosecution at the Managing IP ...
Jacqueline Murphy - June 20, 2022 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022 We are delighted to once again be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2022.
Robert Watson - October 18, 2021 Missed the 30 September 2021 deadline for refiling RCDs pending at 31 December 2020 in the UK – there may be a solution! As widely discussed, 30 September 2021 was the deadline for refiling Registered Community Design ...
Kate O'Rourke - October 14, 2021 Uncharted territory – your IP rights post-Brexit 30 September saw the passing of the final deadline for owners of EU trade mark and design rights to ...
Robert Watson - August 12, 2021 Intellectual property landscape 2021 - key questions answered Partner Robert Watson recently participated in a Corporate LiveWire virtual round table where ...
Robert Watson - July 2, 2021 Seeing Double at the EPO – what was G4/19 actually about? Whether double patenting, the granting of more than one patent for the same invention, should be ...
Jacqueline Murphy - July 2, 2021 IAM Patent 1000: The World’s Leading Patent Professionals 2021 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - June 17, 2021 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021 We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2021. As one of only ...
Robert Watson - March 11, 2021 Defending D-Line From its first steps in North Shields to international stature, how has this company’s approach to ...
Robert Watson - February 16, 2021 Robert Watson appointed to EPO’s Standing Advisory Committee (SACEPO) Robert Watson has been appointed to the EPO’s Standing Advisory Committee (SACEPO) for its ...
Robert Watson - February 16, 2021 For UK designs, we’re entering exciting times As part of our Thought Leaders series, Mewburn Ellis Partner Robert Watson explores the ...
Robert Watson - February 5, 2021 Out of Oz: the remarkable life and times of AMP945 Bringing a new cancer treatment to the public can be a complex process, as Alex Eliseev finds out.
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Jacqueline Murphy - June 16, 2020 IAM Patent 1000: The World’s Leading Patent Professionals 2020 We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...
Jacqueline Murphy - May 5, 2020 IP STARS 2020: The leading practitioners in IP Congratulations to Sofia Arenal, Chris Denison, Stephen Gill, Sean Jauss, Kate O’Rourke, Nick ...
Jacqueline Murphy - June 17, 2019 Managing Intellectual Property: IP Stars 2019 We are delighted to be ranked in Managing Intellectual Property: IP Stars for 2019.
Jacqueline Murphy - June 17, 2019 IAM Patent 1000, 2019 We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...
Julie Carlisle - May 20, 2019 Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable An Expert View column originally published in The Pharma Letter. Read the original article here. ...
Robert Watson - March 21, 2019 Numbering system for re-registered design rights and comparable trade marks The UK enacted the EU Withdrawal Act 2018 which provides the basis for how EU law will be converted ...
